CLASS I ONGOING Device recall · Reported 10 Sep 2025 · FDA Enforcement Report

Watchman FXD Curve Access System Dbl, US, Material Number recalled

Boston Scientific is recalling Watchman FXD Curve Access System Dbl, US, Material Number (UPN) M635TU80020. The recall was initiated on 29 Jul 2025 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesGTIN 00191506013813, ALL NON-EXPIRED BATCHES
Quantity recalled340185 units in total

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2435-2025
FDA event ID
97363
Recalling firm
Boston Scientific, Maple Grove, MN
Classification
Class I
Status
Ongoing
Recall initiated
29 Jul 2025
FDA classified
29 Aug 2025
Reported
10 Sep 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

29 Jul 2025Recall initiated by company
29 Aug 2025Classified by FDA+31 days
10 Sep 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Boston Scientific has identified a higher likelihood of air embolism events when procedures are performed without positive pressure-controlled ventilation. According to published literature and clinical data, in percutaneous procedures requiring transseptal access to the left atrium when conscious or deep sedation is used, patients have an approximately three-times higher risk (U.S. study) of negative left atrium pressure and air ingress. This risk is especially prevalent in patients with pre-existing low left atrial pressure, hypovolemia, and partial upper airway collapse.

Product as listed by the FDA

WATCHMAN FXD Curve Access System Dbl, US, Material Number (UPN) M635TU80020; intended to provide vascular and transseptal access for the family of WATCHMAN FLX LAAC Devices with Delivery Systems.

Where it was distributed

Worldwide.

Questions about this recall

Why was it recalled?

Boston Scientific has identified a higher likelihood of air embolism events when procedures are performed without positive pressure-controlled ventilation. According to published literature and clinical data, in percutaneous procedures requiring transseptal access to the left atrium when conscious or deep sedation is used, patients have an approximately three-times higher risk (U.S. study) of negative left atrium pressure and air ingress. This risk is especially prevalent in patients with pre-existing low left atrial pressure, hypovolemia, and partial upper airway collapse.

Which lots are affected?

GTIN 00191506013813, ALL NON-EXPIRED BATCHES

Where was it sold?

Worldwide.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

10 other products · FDA event 97363

This product is part of a recall event; the main page for the event is Watchman TruSeal Access System SGL, US, Material Number recalled.

More recalls from Boston Scientific

All 628

Other Heart & Vascular Devices recalls

All 6,217